Measles antibody in vaccinated human immunodeficiency virus type 1-infected children

Pediatrics

Volumn 97, Issue 5, 1996, Pages 653-657

  Arpadi, Stephen M ^a,f   Markowitz, Lauri E ^b   Baughman, Andrew L ^b   Shah, Kiran ^c   Adanm, Henry ^d   Wiznia, Andrew ^a   Lambert, Genevieve ^a   Dobroszycki, Joanna ^a   Heath, Janet L ^e   Bellini, William J ^e  

^a BRONX LEBANON HOSPITAL CENTER   (United States)

^b CENTERS FOR DIS CONTR AND PREV   (United States)

^c Lincoln Hospital   (United States)

^d ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^e CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^f ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEASLES ANTIBODY; MEASLES VACCINE;

ANTIBODY DETECTION; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CHILD; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MEASLES; MEASLES VACCINATION; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

ADOLESCENT; AGE FACTORS; ANTIBODIES, VIRAL; CHILD; CHILD, PRESCHOOL; ENZYME-LINKED IMMUNOSORBENT ASSAY; HIV INFECTIONS; HIV-1; HUMANS; IMMUNE TOLERANCE; IMMUNIZATION, SECONDARY; IMMUNOCOMPROMISED HOST; INFANT; LYMPHOCYTE SUBSETS; MEASLES VACCINE; MEASLES VIRUS; NEUTRALIZATION TESTS; NEW YORK CITY; RISK FACTORS; TIME FACTORS; VACCINATION;

EID: 0030009484     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Albano EA, Pizzo PP. The evolving population of immunocompromised children. Ped Inf Dis J. 1988;7:S79-S86
2. Kaplan LJ, Daum R, Smaron M, et al. Severe measles in immunocompromised patients. JAMA. 1992;267:237-1241
3. Centers for Disease Control and Prevention. Summary of notifiable diseases. United States MMWR. 1992;41(55):67
4. Friedman S. Measles in New York City. JAMA 1991;266:1220 (letter)
5. Sension MG, Quinn T, Markowitz LE, et al. Measles in hospitalized children infected with human immunodeficiency virus. Am J Dis Child 1988;142 1271-1272
6. Statement on immunization for immunocompromised persons. MMWR. 1995;43:RR-1
7. Special Programme on AIDS and Expanded Programme on Immunization Human immunodeficiency virus infection and routine childhood immunization. Geneva: WHO/EPI/GAG/1987 WP8 Rev 1
8. Krasinski K, Borkowsky W. Measles and measles immunity in children with human immunodeficiency virus. JAMA. 1989;261:2512-2516
9. Palumbo P, Hoyt L, Demasio K, et al. Population-based study of measles and measles immunization in human immunodeficiency virus infected children. Pedtatr Inf Dis J 1992;11:1008-1014
10. 1994 Revised classification system for human immunodeficiency virus infection in children less than 13 years of age. MMWR. 1994;43:1-8
11. The measles emergency, an epidemic alert. City Health Information, The New York City Dept. of Health. 1991;10,3:1-2
12. Erdman DD, Anderson LJ, Adams DR, et al. Evaluation of monoclonal antibody-based capture enzyme immunoassays for detection of specific antibodies to measles virus. J Clin Microbiol. 1991;29:1466-1471
13. The European Collaborative Study. Age-related standards for Tlymphocyte subsets based on uninfected children born to human immunodeficiency virus 1-infected women. Pediatr Inf Dis J 1992;11: 1018-1026
14. Fleiss JL. Statistical Methods for Rates and Proportions. (2nd ed.). John Wiley & Sons, Inc, New York; 1981
15. Hosmer DW, Lemeshow S. Model-Building Strategies and Methods for Logistic Regression. In: Applied Logistic Regression. John Wiley & Sons, Inc., New York; 1989:82-134
16. SAS Institute, Inc The LOGISTIC Procedure: SAS/STAT User's Guide. Version 6, Fourth Edition, Volume 2, Cary, NC: SAS Institute, Inc; 1989:1071-1126
17. Watson JC, Pearson JA, Markowitz LE, et al. An evaluation of measles revaccination among school-entry-aged children. Pediatrics. 1995;In press
18. Lane HC, Masur L, Edgar C, et al. Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome. N Engl J Med. 1983;309:453
19. Shannon KM, Ammann AJ. Acquired immunodeficiency in childhood. J Pediatr. 1985;106:322-342
20. Borkowsky W, Rigaud M, Krasinski D, et al. Cell-mediated and humoral immune responses in children infected with human immunodeficiency virus during the first four years of life. J Pediatr. 1992;120: 371-375
21. Borkowsky W, Steele CJ, Grubman S, et al. Antibody response to bacterial toxoids in children infected with human immunodeficiency virus. J Pediatr. 1987;110:563-566
22. Rudy BJ, Rutstein RM, Pinto-Martin J. Responses to measles immunization in children infected with human immunodeficiency virus. J Pediatr. 1994;125:72-74
23. Wilkins J, Uehrle PF. Additional evidence against measles vaccine administration to infants less than 12 months of age: Altered immune response following active/passive immunization. J Pediatr. 1979;94: 865-869
24. Embree JE, Datta P, Stack WW. Increased risk of early measles in infants of human immunodeficiency type 1-seropositive mothers. J Infect Dis. 1992;165:262-267